Search Results - "Gaber, A.O"

The Lung Transplant Risk Model - A Nationally Validated Tool for Pre-Transplant Risk Assessment by Chan, E.Y, Nguyen, D.T, Sinha, N, Kaleekal, T.S, Goodarzi, A, Youssef, J.G, Bruckner, B.A, Suarez, E.E, Scheinin, S.A, Graviss, E.A, Gaber, A.O

Get full text

Liver Transplantation in an Adult With Adenomatosis and Congenital Absence of the Portal Vein: A Case Report by Gordon-Burroughs, S, Balogh, J, Weiner, M.A, Monsour, H.P, Schwartz, M.R, Gaber, A.O, Ghobrial, R.M

“…Abstract Congenital absence of the portal vein (CAPV) is a rare congenital anomaly in which the superior mesenteric veins (SMV) and splenic veins converge and…”
Get full text

Identification of Independent Risk Factors for De Novo DSA Development Through Prospective Monitoring by Islam, A.K, Jyothula, S, Devos, J, Teeter, L, Graviss, E, Moore, L, Sinha, N, Kaleekal, T, Mankidy, B, Scheinin, S, Loebe, M, Bruckner, B, Ren, D, Gaber, A.O

Get full text

Outcomes of Living Donor Renal Transplants With a Negative Cross-Match and Pretransplant Donor-Specific Antibody by Knight, R.J, Devos, J.M, Patel, S.J, Land, G, Moore, L.W, Gaber, L, Gaber, A.O

“…Abstract Introduction Management of renal transplant recipients with a negative complement-dependent cytotoxicity-antihuman globulin (CDC-AHG) cross-match and…”
Get full text

QS480. Surgical Management of Giant Symptomatic Liver Hemangioma by Zibari, G.B, Dabbous, H.M, Gaber, A.O, Shokouh-Amiri, H

Get full text

Simultaneous Kidney-Pancreas Transplantation for End-Stage Renal Disease Patients with Insulin-Dependent Diabetes and Detectable C-Peptide by Knight, R.J, Lawless, A, Patel, S.J, Gaber, A.O

“…Abstract Introduction There is controversy regarding the place of simultaneous pancreas-kidney (SPK) transplantation in end-stage renal disease (ESRD) patients…”
Get full text

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors by Orandi, Babak J, Luo, Xun, Massie, Allan B, Garonzik-Wang, Jacqueline M, Lonze, Bonne E, Ahmed, Rizwan, Van Arendonk, Kyle J, Stegall, Mark D, Jordan, Stanley C, Oberholzer, Jose, Dunn, Ty B, Ratner, Lloyd E, Kapur, Sandip, Pelletier, Ronald P, Roberts, John P, Melcher, Marc L, Singh, Pooja, Sudan, Debra L, Posner, Marc P, El-Amm, Jose M, Shapiro, Ron, Cooper, Matthew, Lipkowitz, George S, Rees, Michael A, Marsh, Christopher L, Sankari, Bashir R, Gerber, David A, Nelson, Paul W, Wellen, Jason, Bozorgzadeh, Adel, Gaber, A. Osama, Montgomery, Robert A, Segev, Dorry L

“…This multicenter trial showed that, despite immunologic challenges, recipients of kidney transplants from HLA-incompatible live donors had a survival benefit…”
Get full text

Single Lung Transplantation for Pulmonary Fibrosis Secondary to COVID-19 by He, Y.A., Chihara, R.K., Suarez, E.E., Huang, H.J., Goodarzi, A., Yau, S.W., Youssef, J.G., Gaber, A.O., MacGillivray, T.E., Chan, E.Y.

“…As of April 2021, 78 lung transplants (LTx) were performed for a diagnosis of COVID-19: 50 for COVID-19 ARDS and 28 for pulmonary fibrosis. Bilateral LTx has…”
Get full text

New‐Onset Diabetes After Transplantation: Results From a Double‐Blind Early Corticosteroid Withdrawal Trial by Pirsch, J. D., Henning, A. K., First, M. R., Fitzsimmons, W., Gaber, A. O., Reisfield, R., Shihab, F., Woodle, E. S.

“…New‐onset diabetes after transplantation (NODAT) is an important complication following kidney transplantation. Data from the 5‐year early steroid withdrawal…”
Get full text

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study by Orandi, B. J., Garonzik‐Wang, J. M., Massie, A. B., Zachary, A. A., Montgomery, J. R., Van Arendonk, K. J., Stegall, M. D., Jordan, S. C., Oberholzer, J., Dunn, T. B., Ratner, L. E., Kapur, S., Pelletier, R. P., Roberts, J. P., Melcher, M. L., Singh, P., Sudan, D. L., Posner, M. P., El‐Amm, J. M., Shapiro, R., Cooper, M., Lipkowitz, G. S., Rees, M. A., Marsh, C. L., Sankari, B. R., Gerber, D. A., Nelson, P. W., Wellen, J., Bozorgzadeh, A., Gaber, A. O., Montgomery, R. A., Segev, D. L.

“…Incompatible live donor kidney transplantation (ILDKT) offers a survival advantage over dialysis to patients with anti‐HLA donor‐specific antibody (DSA)…”
Get full text

HPB training in asts transplant fellowships: more pancreas please by Borscheid, R., Cho, E., Lewis, F., Osman, H., Kurtz, J., Saharia, A., Gaber, A.O., Jeyarajah, D.R.

Get full text

The Effect of Menses on the Measurement of Proteinuria and Estimation of Dietary Intake in US Females by Moore, L.W, Parrott, J.S, Rigassio-Radler, D, Byham-Gray, L.D, Gaber, A.O

“…An abstract of a study by Moore et al examining the effect of menses on proteinuria and assessment of dietary protein (DPI) and energy intake (DEI) in females…”
Get full text

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation by Busque, S., Cantarovich, M., Mulgaonkar, S., Gaston, R., Gaber, A. O., Mayo, P. R., Ling, S., Huizinga, R. B., Meier‐Kriesche, H‐U.

“…Voclosporin (VCS, ISA247) is a novel calcineurin inhibitor being developed for organ transplantation. PROMISE was a 6‐month, multicenter, randomized,…”
Get full text

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients by Abudayyeh, A., Hamdi, A., Lin, H., Abdelrahim, M., Rondon, G., Andersson, B. S., Afrough, A., Martinez, C. S., Tarrand, J. J., Kontoyiannis, D. P., Marin, D., Gaber, A. O., Salahudeen, A., Oran, B., Chemaly, R. F., Olson, A., Jones, R., Popat, U., Champlin, R. E., Shpall, E. J., Winkelmayer, W. C., Rezvani, K.

“…Nephropathy due to BK virus (BKV) infection is an evolving challenge in patients undergoing hematopoietic stem cell transplantation (HSCT). We hypothesized…”
Get full text

Transplantation for Hepatocellular Carcinoma: Is There a Tumor Size Limit? by Daoud, A., Teeter, L., Ghobrial, R.M., Graviss, E.A., Mogawer, S., Sholkamy, A., El-Shazli, M., Gaber, A.O.

“…The advent of tumor-size–based criteria (Milan and University of California, San Francisco [UCSF]) for the transplantation of hepatocellular carcinomas (HCC)…”
Get full text

Combination Drug Products for HIV—A Word of Caution for the Transplant Clinician by Patel, S. J., Kuten, S. A., Musick, W. L., Gaber, A. O., Monsour, H. P., Knight, R. J.

“…Modern‐day treatment regimens for human immunodeficiency virus (HIV) are not only highly effective, but are now more often available as convenient fixed‐dose…”
Get full text

Suitability of Estimated Glomerular Filtration Rate for Live Kidney Donor Selection by Akhimiona, C.O., Nguyen, D.T., Graviss, E.A., Gaber, A.O., Suki, W.N.

“…The assessment of the glomerular filtration rate (GFR) in kidney donor candidates is required for determining donor candidate acceptability. This assessment…”
Get full text

Observations on the use of cidofovir for BK virus infection in renal transplantation by Kuten, S.A., Patel, S.J., Knight, R.J., Gaber, L.W., DeVos, J.M., Gaber, A.O.

“…Background In renal transplantation, BK virus infection can result in significant graft nephropathy and loss. While reduction in immunosuppression (IS) is…”
Get full text

Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm by Balogh, J., Gordon-Burroughs, S., Schwarz, P., Galati, J., McFadden, R.A., Cusick, M., Snyder, M.J., Bailey, H.R., Weiner, M., Wong, A., Ochoa, R.A., Saharia, A., Gaber, A.O., Ghobrial, R.M.

“…In patients with portal hypertension, ectopic varices can develop at any site along the gastrointestinal tract outside the classically described…”
Get full text

Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study by Shihab, F. S., Lee, S. T., Smith, L. D., Woodle, E. S., Pirsch, J. D., Gaber, A. O., Henning, A. K., Reisfield, R., Fitzsimmons, W., Holman, J.

“…As corticosteroid‐sparing protocols are increasingly utilized in kidney transplant recipients, it is crucial to understand potential drug interactions between…”
Get full text